StockClub

TRDA

TRDAEntrada Therapeutics, Inc.$ --
Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc.

TRDA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
1M USD
YoY -96.5%
Operating Income
-42M USD
YoY -619.4%
Net Income
-39M USD
YoY -3562.8%
EPS
-0.95$
YoY -3529.6%

Revenue

$25.4M
FY2024 Q1$59.1M
$59.1M
Q1
FY2024 Q2$153.8M
$153.8M
Q2
FY2024 Q3$173.4M
$173.4M
Q3
FY2024 Q4$210.8M
$210.8M
Q4
FY2025 Q1$20.6M
$20.6M
Q1
FY2025 Q2$22.5M
$22.5M
Q2
FY2025 Q3$24.1M
$24.1M
Q3
FY2025 Q4$25.4M
$25.4M
Q4
Actual
$-185.4M (-87.9%)

Net Income

$-143.8M
FY2024 Q1$23.5M
$23.5M
Q1
FY2024 Q2$78.5M
$78.5M
Q2
FY2024 Q3$64.5M
$64.5M
Q3
FY2024 Q4$65.6M
$65.6M
Q4
FY2025 Q1$-17.3M
$-17.3M
Q1
FY2025 Q2$-60.5M
$-60.5M
Q2
FY2025 Q3$-104.6M
$-104.6M
Q3
FY2025 Q4$-143.8M
$-143.8M
Q4
Actual
$-209.4M (-319.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022MISS
Actual:$0
Est:$43.4M
FY2022MISS
$0
FY2023MISS
Actual:$129M
Est:$239.4M
FY2023MISS
$129M
FY2024BEAT
Actual:$210.8M
Est:$186.5M
FY2024BEAT
$210.8M
FY2025MISS
Actual:$25.4M
Est:$30.5M
FY2025MISS
$25.4M

Analyst Estimates